Dana Ziliak

499 total citations
11 papers, 327 citations indexed

About

Dana Ziliak is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Dana Ziliak has authored 11 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Dana Ziliak's work include Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer therapeutics and mechanisms (2 papers). Dana Ziliak is often cited by papers focused on Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (4 papers) and Cancer therapeutics and mechanisms (2 papers). Dana Ziliak collaborates with scholars based in United States, Australia and China. Dana Ziliak's co-authors include R. Stephanie Huang, Eric R. Gamazon, Hae Kyung Im, Nancy J. Cox, Yujia Wen, Bonnie LaCroix, M. Eileen Dolan, Wasim K. Bleibel, Claudia Wing and Shiwei Duan and has published in prestigious journals such as PLoS ONE, Cancer Research and The American Journal of Human Genetics.

In The Last Decade

Dana Ziliak

11 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dana Ziliak United States 8 236 206 43 33 21 11 327
Xinhong Wang China 11 246 1.0× 179 0.9× 30 0.7× 38 1.2× 9 0.4× 16 332
Kirti Shukla Germany 5 331 1.4× 297 1.4× 18 0.4× 25 0.8× 10 0.5× 6 378
Guiqiang Du China 8 217 0.9× 141 0.7× 98 2.3× 55 1.7× 6 0.3× 12 340
Giuseppe S. A. Longo-Sorbello United States 4 294 1.2× 237 1.2× 23 0.5× 44 1.3× 14 0.7× 5 378
Edward Grimley United States 10 178 0.8× 60 0.3× 27 0.6× 56 1.7× 6 0.3× 11 249
D Surekha India 12 198 0.8× 50 0.2× 58 1.3× 107 3.2× 36 1.7× 22 340
Bonnie LaCroix United States 9 200 0.8× 154 0.7× 34 0.8× 22 0.7× 3 0.1× 12 270
Alina Simerzin Israel 6 148 0.6× 131 0.6× 26 0.6× 17 0.5× 9 0.4× 8 249
Olì Maria Victoria Grober Italy 7 280 1.2× 140 0.7× 81 1.9× 66 2.0× 4 0.2× 8 390

Countries citing papers authored by Dana Ziliak

Since Specialization
Citations

This map shows the geographic impact of Dana Ziliak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana Ziliak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana Ziliak more than expected).

Fields of papers citing papers by Dana Ziliak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana Ziliak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana Ziliak. The network helps show where Dana Ziliak may publish in the future.

Co-authorship network of co-authors of Dana Ziliak

This figure shows the co-authorship network connecting the top 25 collaborators of Dana Ziliak. A scholar is included among the top collaborators of Dana Ziliak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana Ziliak. Dana Ziliak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Morrison, Gladys, Bonnie LaCroix, Dana Ziliak, et al.. (2016). Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients. Oncotarget. 7(25). 38359–38366. 2 indexed citations
2.
Ziliak, Dana, et al.. (2014). Integrative “Omic” Analysis for Tamoxifen Sensitivity through Cell Based Models. PLoS ONE. 9(4). e93420–e93420. 7 indexed citations
3.
LaCroix, Bonnie, Eric R. Gamazon, Hae Kyung Im, et al.. (2014). Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity. BMC Genomics. 15(1). 292–292. 20 indexed citations
4.
Ziliak, Dana, Hae Kyung Im, Eric R. Gamazon, et al.. (2013). Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation. Annals of Oncology. 24(7). 1867–1873. 9 indexed citations
5.
Ziliak, Dana, Eric R. Gamazon, Bonnie LaCroix, et al.. (2012). Genetic Variation That Predicts Platinum Sensitivity Reveals the Role of miR-193b* in Chemotherapeutic Susceptibility. Molecular Cancer Therapeutics. 11(9). 2054–2061. 30 indexed citations
6.
Gamazon, Eric R., Dana Ziliak, Hae Kyung Im, et al.. (2012). Genetic Architecture of MicroRNA Expression: Implications for the Transcriptome and Complex Traits. The American Journal of Human Genetics. 90(6). 1046–1063. 72 indexed citations
7.
Gamazon, Eric R., Hae Kyung Im, Peter H. O’Donnell, et al.. (2011). Comprehensive Evaluation of the Contribution of X Chromosome Genes to Platinum Sensitivity. Molecular Cancer Therapeutics. 10(3). 472–480. 6 indexed citations
8.
Huang, R. Stephanie, Eric R. Gamazon, Dana Ziliak, et al.. (2011). Population differences in microRNA expression and biological implications. RNA Biology. 8(4). 692–701. 127 indexed citations
9.
Ziliak, Dana, Peter H. O’Donnell, Hae Kyung Im, et al.. (2011). Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers. Translational research. 157(5). 265–272. 36 indexed citations
10.
Wen, Yujia, et al.. (2011). Chemotherapeutic-induced apoptosis. Pharmacogenetics and Genomics. 21(8). 476–488. 17 indexed citations
11.
Huang, R. Stephanie, Sharon E. Johnatty, Eric R. Gamazon, et al.. (2010). Abstract 2761: Germline polymorphism discovered via a cell-based genome-wide approach predicts platinum response in ovarian and head and neck cancers. Cancer Research. 70(8_Supplement). 2761–2761. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026